FDA approves hepatitis C drug
BY Advocate.com Editors
October 15 2003 12:00 AM ET
The Food and Drug Administration on Monday approved Schering-Plough's prefilled pen-like syringe that contains the company's PEG-Intron hepatitis C treatment. The device, called the PEG-Intron Redipen, was designed to be easier to use than traditional syringes and vials of the medication. It is expected to be available in the United States in early 2004. PEG-Intron Redipen is already sold in Europe. Hepatitis C is a common coinfection among HIV-positive people and is one of the leading killers of people who are infected with HIV. Hepatitis C is commonly transmitted through contact with infected blood, but studies have shown it may also be transmitted through sexual contact.
- WATCH: Kentucky Clerk Defies Court Again, Turns Away Same-Sex Couple a Third Time
- TBT: Mid-Century Dreamboats
- Trayvon Martin Killer George Zimmerman Proves He's a Racist Homophobe
- Why This Latina Photographer Documented the Moment She Came Out to Her Parents
- WATCH: Did a Texas Chef Refuse to Cater This Couple's Wedding?
- Illinois Bishop Reminds Gay Parents: Catholic Schools Will Teach You're Sinning